* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.
A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
Portfolio holdings
Top ten positions
Represents the top ten positions in NCDL based on Fair Value as of September 30, 2024
Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
---|---|---|---|---|
FoodScience LLC | 111,781 | Consumer Goods: Non-durable | Equity Investment | |
Forefront Dermatology | 3,143,105 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 4.25% |
Fresh Edge | 71,362 | Beverage, Food & Tobacco | Equity Investment | |
Fresh Edge | 801,232 | Beverage, Food & Tobacco | Equity Investment | |
Fresh Edge | 783,478 | Beverage, Food & Tobacco | Subordinated Debt | S + 4.50% |
Fresh Edge | 3,923,508 | Beverage, Food & Tobacco | Subordinated Debt | S + 4.50% |
Fresh Edge | 927,125 | Beverage, Food & Tobacco | Subordinated Debt | S + 4.50% |
GHR Healthcare | 7,880,789 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.00% |
GHR Healthcare | 3,664,246 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.25% |
GHR Healthcare | 6,204,874 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.00% |
GHR Healthcare | 4,830,328 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.00% |
GHR Healthcare (Delayed Draw) | -15,061 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.25% |
GHR Healthcare (Delayed Draw) | -45,202 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.25% |
GHR Healthcare (Delayed Draw) | 1,940,841 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.00% |
Gabriel Partners, LLC | 9,119,977 | Services: Business | First Lien Term Loan | S + 6.25% |
Gabriel Partners, LLC | 3,764,700 | Services: Business | First Lien Term Loan | S + 6.25% |
Gabriel Partners, LLC (Delayed Draw) | 1,519,339 | Services: Business | First Lien Term Loan | S + 6.25% |
Gannett Fleming | 1,140,625 | Construction & Building | Equity Investment | |
Gannett Fleming | 17,605,998 | Construction & Building | First Lien Term Loan | S + 4.50% |
Gannett Fleming | -31,331 | Construction & Building | Revolving Loan | S + 4.50% |
Gannett Fleming | 1,621,977 | Construction & Building | Equity Investment | |
Genesee Scientific LLC | 5,328,918 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.75% |
Genesee Scientific LLC (Delayed Draw) | 1,395,017 | Healthcare & Pharmaceuticals | First Lien Term Loan | S + 5.75% |
Go Engineer | 5,290,837 | High Tech Industries | First Lien Term Loan | S + 5.00% |
Go Engineer | 11,354,526 | High Tech Industries | First Lien Term Loan | S + 5.00% |
Go Engineer (Delayed Draw) | 3,092,458 | High Tech Industries | First Lien Term Loan | S + 5.00% |
Good2Grow | 8,623,512 | Containers, Packaging & Glass | First Lien Term Loan | S + 4.50% |
Good2Grow | 6,313,931 | Containers, Packaging & Glass | First Lien Term Loan | S + 5.50% |
Good2Grow | 14,277,200 | Containers, Packaging & Glass | First Lien Term Loan | S + 4.75% |
Halo Buyer, Inc. | 5,170,615 | Consumer Goods: Durable | First Lien Term Loan | S + 4.50% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at June 30, 2024. As of June 30, 2024, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 5.34%, 5.32%, 5.25%, and 5.04% respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.